Navigation Links
MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
Date:2/21/2008

WARREN, N.J., Feb. 21 /PRNewswire/ -- MonoSol Rx, a drug delivery company specializing in dissolving thin film pharmaceutical products, today announced that it has successfully completed a pilot clinical study for its thin film formulation of ondansetron, a selective 5-HT3 receptor antagonist used in the prevention and treatment of nausea and vomiting.

MonoSol Rx's thin film formulation of ondansetron was studied against GlaxoSmithKline's Zofran ODT(R) product. Based on the results of the study, MonoSol Rx is moving immediately to pivotal trials to enable drug submissions both in the US and Europe. The Company expects to file with the appropriate regulatory authorities in 2008.

A. Mark Schobel, president and chief executive officer of MonoSol Rx, stated, "Successful completion of this pilot study marks an important step towards commercializing what we believe is a product with significant benefits over existing formulations of ondansetron. Our thin film formulation of ondansetron is particularly well suited for the target patient population because individuals who are prescribed the drug often have difficulty swallowing due to extreme nausea caused by chemotherapy, radiotherapy and surgical procedures. Incorporating ondansetron into a great-tasting thin film formulation that dissolves quickly in the mouth allows the drug to be easily administered without water, making it more palatable and less likely to cause additional discomfort."

MonoSol Rx's formulation of ondansetron is a new oral formulation expected to be introduced to the market next year. Its indications are the prevention of Chemotherapy-Induced Nausea and Vomiting (CINV), prevention of nausea and vomiting associated with radiotherapy, and prevention of Post-Operative Nausea and Vomiting (PONV).

MonoSol Rx's thin film technology utilizes strategic and proprietary intellectual property that ensures predictable in-vivo performance and provides superior characteristics over
'/>"/>

SOURCE MonoSol Rx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Children,s National Health System has announced ... 5 p.m. EDT for its "Make Your Medical ... continued strong interest from inventors.  Two ... to the winning presentations at the Sheikh Zayed Institute ... Children,s National in October. For competition details,  click ...
(Date:9/22/2014)... 2014 Decision Resources Group finds that by the ... be worth $2 billion (U.S. dollars), increasing at a compound ... years (to 2018). This growth comes as Chile ... and 4.9 percent expected over the next three to five ... but highly competitive. The pharmaceutical market is dominated by prescription ...
(Date:9/22/2014)... DIEGO , Sept. 22, 2014  Aethlon ... targeted therapeutic devices to address infectious disease, cancer ... Defense Advanced Research Projects Agency (DARPA) has informed ... option to proceed with year four of a ... Aethlon on September 30, 2011 under DARPA,s Dialysis-Like ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4
(Date:9/22/2014)... Steven Reinberg HealthDay ... Pediatricians are urging that all children aged 6 months and ... American Academy of Pediatrics updated their influenza vaccine recommendations to ... of vaccine to build immunity. The AAP also wants parents ... kids the nasal spray vaccine instead of the flu shot ...
(Date:9/22/2014)... Hamilton, ON (September 22, 2014) McMaster scientists have ... a new class of antibiotics. , Although dozens ... looked at how a certain part of bacteria are ... stopping it. , The discovery is important as ... is making the cures for infections ineffective. The World ...
(Date:9/22/2014)... Madison, WI (PRWEB) September 22, 2014 ... companies in the United States, promotes National ... company believes that all individuals should have access ... function in aging. , The demand for products ... living longer than ever before. For over six ...
(Date:9/22/2014)... 2014 (HealthDay News) -- Scans of young children,s ... read. This finding could potentially allow doctors to ... early on, preliminary research suggests. "Early identification ... dyslexia as well as most neurodevelopmental disorders," the ... professor of child and adolescent psychiatry at University ...
(Date:9/22/2014)... Nanuet, NY (PRWEB) September 22, 2014 ... Blindness, Rockland Chrysler Jeep Dodge Ram is launching an ... Blind Egg Challenge (#blindeggchallenge or #ffbBEC) aims to raise ... Egg Challenge involves throwing an egg in the air ... at least three others and if a nominee does ...
Breaking Medicine News(10 mins):Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:Can Brain Scans Help Predict Young Children's Reading Abilities? 2Health News:Blind Egg Challenge Raises Awareness for Foundation Fighting Blindness 2
... from the Virginia Bioinformatics Institute (VBI) at Virginia Tech ... virulence proteins in oomycete plant pathogens that enables the ... protein region contains the amino acid sequence motifs RXLR ... virulence proteins across the membrane surrounding plant cells without ...
... concerns often go unspoken and ... unaddressed., ... patients frequently do not raise all of,their concerns about proposed procedures. A ... Joint Surgery found that patients age,60 or older have many concerns and ...
... World Congress on Interventional Therapies for Type 2 Diabetes ... and public health to discuss the role of surgery ... 2 diabetes. The World Congress has been formed to ... for health care systems and patient care. , Led ...
... Edouard Approaches, WASHINGTON, Aug. 4 Hurricane season ... the Gulf of Mexico and,Hurricane Dolly having just left. ... needs of people whose homes were flooded and damaged ... prepare for,potential hurricane conditions along the coasts of Louisiana ...
... Chan, and presidents from Africa and Latin,America call for ... with,men, MEXICO CITY, Aug. 4 A day ... Organization called attention to,the need to combat AIDS among ... first comprehensive report exposing the failure of governments and,global ...
... LAFAYETTE, Ind. - The methods mothers use to control their ... negative impact on their child,s self-esteem and behavior, according to ... parents how to interact with their children based on one ... have a propensity for being verbally aggressive have a tendency ...
Cached Medicine News:Health News:Key to virulence protein entry into host cells discovered 2Health News:Video: Communication is Key to Ease Worry about Orthopaedic Surgery 2Health News:Video: Communication is Key to Ease Worry about Orthopaedic Surgery 3Health News:1st World Congress On Interventional Therapies for Type 2 Diabetes 2Health News:1st World Congress On Interventional Therapies for Type 2 Diabetes 3Health News:1st World Congress On Interventional Therapies for Type 2 Diabetes 4Health News:American Red Cross on the Gulf Coast: Storms Coming and Going 2Health News:American Red Cross on the Gulf Coast: Storms Coming and Going 3Health News:As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM 2Health News:As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM 3Health News:Study: verbal aggression may affect children's behavior 2
Cloward Dowel CL18 Used for Anterior Cervical Fusion and are preserved by Freeze-dried method....
8 mm S Graftech cervical spacer....
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
... is a useful addition to ... It may be used in ... and orbital regions in all ... strength over the Leibinger Micro ...
Medicine Products: